Design Therapeutics Inc (DSGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||
| Net Income | -4,425 | -2,105 | -663 |
| Depreciation Amortization | -68 | -11 | 2 |
| Other Working Capital | -1,399 | -1,902 | -2,040 |
| Other Operating Activity | 67 | 52 | 42 |
| Operating Cash Flow | $-5,825 | $-3,966 | $-2,659 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -35,497 | -38,746 | -39,247 |
| PPE Investments | -62 | N/A | N/A |
| Investing Cash Flow | $-35,559 | $-38,746 | $-39,247 |
| Cash Flows From Financing Activities | |||
| Change In Short Term Borrowing | 200 | 200 | 200 |
| Other Financing Activity | 44,331 | 44,331 | 44,331 |
| Financing Cash Flow | $44,531 | $44,531 | $44,531 |
| Beginning Cash Position | 77 | 77 | 77 |
| End Cash Position | 3,224 | 1,896 | 2,702 |
| Net Cash Flow | $3,147 | $1,819 | $2,625 |
| Free Cash Flow | |||
| Operating Cash Flow | -5,825 | -3,966 | -2,659 |
| Capital Expenditure | -62 | 0 | N/A |
| Free Cash Flow | -5,887 | -3,966 | -2,659 |